Literature DB >> 9314455

Impaired antibody response to pneumococcal capsular polysaccharides and phosphorylcholine in adult patients with a history of bacteremic pneumococcal infection.

K Ekdahl1, J H Braconier, C Svanborg.   

Abstract

The serum antibody response after immunization with a pneumococcal vaccine was analyzed in 46 patients with a history of bacteremic pneumococcal infection and in 36 healthy controls. Seven patients with IgG/IgG2 deficiencies had significantly lower preimmunization and postimmunization levels of antibody to pneumococcal capsular polysaccharides (serotypes 3, 6A, 19F, and 23F) and phosphorylcholine than did the control subjects, while the patients with normal IgG/IgG2 levels did not have a deficient antibody response. For the whole patient group, postimmunization levels of antibody against the serotypes that caused the bacteremias were lower than the levels against other tested serotypes (P < .05). Ten patients vs. one control subject were unable to mount a postimmunization antibody response to the four tested serotypes (P < .05). Six of these 10 nonresponding patients had low IgG/IgG2 levels. The results demonstrate that a poor antibody response to vaccination with capsular polysaccharides, often associated with IgG/IgG2 deficiency, is common in patients with a history of bacteremic pneumococcal infections.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9314455     DOI: 10.1086/513763

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  6 in total

Review 1.  Bacteraemic pneumococcal pneumonia: current therapeutic options.

Authors:  Charles Feldman; Ronald Anderson
Journal:  Drugs       Date:  2011-01-22       Impact factor: 9.546

2.  Highly reduced protection against Streptococcus pneumoniae after deletion of a single heavy chain gene in mouse.

Authors:  Q S Mi; L Zhou; D H Schulze; R T Fischer; A Lustig; L J Rezanka; D M Donovan; D L Longo; J J Kenny
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

3.  Characterization of gene use and efficacy of mouse monoclonal antibodies to Streptococcus pneumoniae serotype 8.

Authors:  Masahide Yano; Liise-anne Pirofski
Journal:  Clin Vaccine Immunol       Date:  2010-11-10

4.  IRAK-4 and MyD88 deficiencies impair IgM responses against T-independent bacterial antigens.

Authors:  Paul J Maglione; Noa Simchoni; Samuel Black; Lin Radigan; Jessica R Overbey; Emilia Bagiella; James B Bussel; Xavier Bossuyt; Jean-Laurent Casanova; Isabelle Meyts; Andrea Cerutti; Capucine Picard; Charlotte Cunningham-Rundles
Journal:  Blood       Date:  2014-10-15       Impact factor: 22.113

5.  Dectin-2-dependent NKT cell activation and serotype-specific antibody production in mice immunized with pneumococcal polysaccharide vaccine.

Authors:  Tomomitsu Miyasaka; Yukiko Akahori; Masahiko Toyama; Namiko Miyamura; Keiko Ishii; Shinobu Saijo; Yoichiro Iwakura; Yuki Kinjo; Yoshitsugu Miyazaki; Kazunori Oishi; Kazuyoshi Kawakami
Journal:  PLoS One       Date:  2013-10-25       Impact factor: 3.240

6.  Serotypes With Low Invasive Potential Are Associated With an Impaired Antibody Response in Invasive Pneumococcal Disease.

Authors:  Nils Littorin; Fabian Uddén; Jonas Ahl; Fredrik Resman; Hans-Christian Slotved; Simon Athlin; Kristian Riesbeck
Journal:  Front Microbiol       Date:  2018-11-15       Impact factor: 5.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.